 | • レポートコード：GIR-105X17343 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、テルビナフィン（ラミシール）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。テルビナフィン（ラミシール）の種類別市場規模（経口、外用）、用途別市場規模（皮膚・粘膜真菌感染症、爪真菌症、気管支喘息、婦人科抗感染症製剤、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・テルビナフィン（ラミシール）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Perrigo、Novartis Pharmaceuticals Corporation、Gokul Pharma、TEVA、Mylan Pharmaceuticals、Pfizer、Sivem Pharmaceuticals、Apotex Corporation、Auro Pharma Inc、PLIVA、Jamp Pharma Corporation、Nu Pharm、Codal Synto、Qd Pharmaceuticals、Pharmel Inc、Smaart Pharmaceutticals、Qilu Pharmaceutical、Qingdao Jinfeng Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、外用 ・用途別分析2016年-2026年：皮膚・粘膜真菌感染症、爪真菌症、気管支喘息、婦人科抗感染症製剤、その他 ・テルビナフィン（ラミシール）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・テルビナフィン（ラミシール）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・テルビナフィン（ラミシール）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・テルビナフィン（ラミシール）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・テルビナフィン（ラミシール）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Terbinafine (Lamisil) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Terbinafine (Lamisil) size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Terbinafine (Lamisil) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Terbinafine (Lamisil) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
External Use
Market segment by Application can be divided into
Fungal Infection Of The Skin And Mucous Membrane
Onychomycosis
Bronchial Asthma
Gynecological Anti-Infection Preparation
Other
The key market players for global Terbinafine (Lamisil) market are listed below:
Perrigo
Novartis Pharmaceuticals Corporation
Gokul Pharma
TEVA
Mylan Pharmaceuticals
Pfizer
Sivem Pharmaceuticals
Apotex Corporation
Auro Pharma Inc
PLIVA
Jamp Pharma Corporation
Nu Pharm
Codal Synto
Qd Pharmaceuticals
Pharmel Inc
Smaart Pharmaceutticals
Qilu Pharmaceutical
Qingdao Jinfeng Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Terbinafine (Lamisil) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Terbinafine (Lamisil), with price, sales, revenue and global market share of Terbinafine (Lamisil) in 2018 and 2019.
Chapter 3, the Terbinafine (Lamisil) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Terbinafine (Lamisil) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Terbinafine (Lamisil) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Terbinafine (Lamisil) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Terbinafine (Lamisil) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Terbinafine (Lamisil) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 External Use
1.3 Market Analysis by Application
1.3.1 Overview: Global Terbinafine (Lamisil) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Fungal Infection Of The Skin And Mucous Membrane
1.3.3 Onychomycosis
1.3.4 Bronchial Asthma
1.3.5 Gynecological Anti-Infection Preparation
1.3.6 Other
1.4 Global Terbinafine (Lamisil) Market Size & Forecast
1.4.1 Global Terbinafine (Lamisil) Sales in Value (2016-2026))
1.4.2 Global Terbinafine (Lamisil) Sales in Volume (2016-2026)
1.4.3 Global Terbinafine (Lamisil) Price by Type (2016-2026) & (US$/G)
1.5 Global Terbinafine (Lamisil) Production Capacity Analysis
1.5.1 Global Terbinafine (Lamisil) Total Production Capacity (2016-2026)
1.5.2 Global Terbinafine (Lamisil) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Terbinafine (Lamisil) Market Drivers
1.6.2 Terbinafine (Lamisil) Market Restraints
1.6.3 Terbinafine (Lamisil) Trends Analysis
2 Manufacturers Profiles
2.1 Perrigo
2.1.1 Perrigo Details
2.1.2 Perrigo Major Business
2.1.3 Perrigo Terbinafine (Lamisil) Product and Services
2.1.4 Perrigo Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis Pharmaceuticals Corporation
2.2.1 Novartis Pharmaceuticals Corporation Details
2.2.2 Novartis Pharmaceuticals Corporation Major Business
2.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product and Services
2.2.4 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Gokul Pharma
2.3.1 Gokul Pharma Details
2.3.2 Gokul Pharma Major Business
2.3.3 Gokul Pharma Terbinafine (Lamisil) Product and Services
2.3.4 Gokul Pharma Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 TEVA
2.4.1 TEVA Details
2.4.2 TEVA Major Business
2.4.3 TEVA Terbinafine (Lamisil) Product and Services
2.4.4 TEVA Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Mylan Pharmaceuticals
2.5.1 Mylan Pharmaceuticals Details
2.5.2 Mylan Pharmaceuticals Major Business
2.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Product and Services
2.5.4 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Terbinafine (Lamisil) Product and Services
2.6.4 Pfizer Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Sivem Pharmaceuticals
2.7.1 Sivem Pharmaceuticals Details
2.7.2 Sivem Pharmaceuticals Major Business
2.7.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Product and Services
2.7.4 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Apotex Corporation
2.8.1 Apotex Corporation Details
2.8.2 Apotex Corporation Major Business
2.8.3 Apotex Corporation Terbinafine (Lamisil) Product and Services
2.8.4 Apotex Corporation Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Auro Pharma Inc
2.9.1 Auro Pharma Inc Details
2.9.2 Auro Pharma Inc Major Business
2.9.3 Auro Pharma Inc Terbinafine (Lamisil) Product and Services
2.9.4 Auro Pharma Inc Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 PLIVA
2.10.1 PLIVA Details
2.10.2 PLIVA Major Business
2.10.3 PLIVA Terbinafine (Lamisil) Product and Services
2.10.4 PLIVA Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Jamp Pharma Corporation
2.11.1 Jamp Pharma Corporation Details
2.11.2 Jamp Pharma Corporation Major Business
2.11.3 Jamp Pharma Corporation Terbinafine (Lamisil) Product and Services
2.11.4 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Nu Pharm
2.12.1 Nu Pharm Details
2.12.2 Nu Pharm Major Business
2.12.3 Nu Pharm Terbinafine (Lamisil) Product and Services
2.12.4 Nu Pharm Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Codal Synto
2.13.1 Codal Synto Details
2.13.2 Codal Synto Major Business
2.13.3 Codal Synto Terbinafine (Lamisil) Product and Services
2.13.4 Codal Synto Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Qd Pharmaceuticals
2.14.1 Qd Pharmaceuticals Details
2.14.2 Qd Pharmaceuticals Major Business
2.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Product and Services
2.14.4 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Pharmel Inc
2.15.1 Pharmel Inc Details
2.15.2 Pharmel Inc Major Business
2.15.3 Pharmel Inc Terbinafine (Lamisil) Product and Services
2.15.4 Pharmel Inc Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Smaart Pharmaceutticals
2.16.1 Smaart Pharmaceutticals Details
2.16.2 Smaart Pharmaceutticals Major Business
2.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Product and Services
2.16.4 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Qilu Pharmaceutical
2.17.1 Qilu Pharmaceutical Details
2.17.2 Qilu Pharmaceutical Major Business
2.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Product and Services
2.17.4 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Qingdao Jinfeng Pharmaceutical
2.18.1 Qingdao Jinfeng Pharmaceutical Details
2.18.2 Qingdao Jinfeng Pharmaceutical Major Business
2.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product and Services
2.18.4 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Terbinafine (Lamisil) Sales by Manufacturer
3.1 Global Terbinafine (Lamisil) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Terbinafine (Lamisil) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Terbinafine (Lamisil)
3.4 Market Concentration Rate
3.4.1 Top 3 Terbinafine (Lamisil) Manufacturer Market Share
3.4.2 Top 6 Terbinafine (Lamisil) Manufacturer Market Share
3.5 Global Terbinafine (Lamisil) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Terbinafine (Lamisil) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Terbinafine (Lamisil) Market Size by Region
4.1.1 Global Terbinafine (Lamisil) Sales in Volume by Region (2016-2026)
4.1.2 Global Terbinafine (Lamisil) Revenue by Region (2016-2026)
4.2 North America Terbinafine (Lamisil) Revenue (2016-2026)
4.3 Europe Terbinafine (Lamisil) Revenue (2016-2026)
4.4 Asia-Pacific Terbinafine (Lamisil) Revenue (2016-2026)
4.5 South America Terbinafine (Lamisil) Revenue (2016-2026)
4.6 Middle East and Africa Terbinafine (Lamisil) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Terbinafine (Lamisil) Sales in Volume by Type (2016-2026)
5.2 Global Terbinafine (Lamisil) Revenue by Type (2016-2026)
5.3 Global Terbinafine (Lamisil) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Terbinafine (Lamisil) Sales in Volume by Application (2016-2026)
6.2 Global Terbinafine (Lamisil) Revenue by Application (2016-2026)
6.3 Global Terbinafine (Lamisil) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Terbinafine (Lamisil) Sales by Type (2016-2026)
7.2 North America Terbinafine (Lamisil) Sales by Application (2016-2026)
7.3 North America Terbinafine (Lamisil) Market Size by Country
7.3.1 North America Terbinafine (Lamisil) Sales in Volume by Country (2016-2026)
7.3.2 North America Terbinafine (Lamisil) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Terbinafine (Lamisil) Sales by Type (2016-2026)
8.2 Europe Terbinafine (Lamisil) Sales by Application (2016-2026)
8.3 Europe Terbinafine (Lamisil) Market Size by Country
8.3.1 Europe Terbinafine (Lamisil) Sales in Volume by Country (2016-2026)
8.3.2 Europe Terbinafine (Lamisil) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Terbinafine (Lamisil) Sales by Type (2016-2026)
9.2 Asia-Pacific Terbinafine (Lamisil) Sales by Application (2016-2026)
9.3 Asia-Pacific Terbinafine (Lamisil) Market Size by Region
9.3.1 Asia-Pacific Terbinafine (Lamisil) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Terbinafine (Lamisil) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Terbinafine (Lamisil) Sales by Type (2016-2026)
10.2 South America Terbinafine (Lamisil) Sales by Application (2016-2026)
10.3 South America Terbinafine (Lamisil) Market Size by Country
10.3.1 South America Terbinafine (Lamisil) Sales in Volume by Country (2016-2026)
10.3.2 South America Terbinafine (Lamisil) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Terbinafine (Lamisil) Sales by Type (2016-2026)
11.2 Middle East & Africa Terbinafine (Lamisil) Sales by Application (2016-2026)
11.3 Middle East & Africa Terbinafine (Lamisil) Market Size by Country
11.3.1 Middle East & Africa Terbinafine (Lamisil) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Terbinafine (Lamisil) Typical Distributors
12.3 Terbinafine (Lamisil) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Terbinafine (Lamisil) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Terbinafine (Lamisil) Revenue by Application, (USD Million), 2021-2026
Table 3. Perrigo Basic Information, Manufacturing Base and Competitors
Table 4. Perrigo Major Business
Table 5. Perrigo Terbinafine (Lamisil) Product and Services
Table 6. Perrigo Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Pharmaceuticals Corporation Major Business
Table 9. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product and Services
Table 10. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Gokul Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Gokul Pharma Major Business
Table 13. Gokul Pharma Terbinafine (Lamisil) Product and Services
Table 14. Gokul Pharma Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. TEVA Basic Information, Manufacturing Base and Competitors
Table 16. TEVA Major Business
Table 17. TEVA Terbinafine (Lamisil) Product and Services
Table 18. TEVA Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Pharmaceuticals Major Business
Table 21. Mylan Pharmaceuticals Terbinafine (Lamisil) Product and Services
Table 22. Mylan Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Terbinafine (Lamisil) Product and Services
Table 26. Pfizer Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sivem Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Sivem Pharmaceuticals Major Business
Table 29. Sivem Pharmaceuticals Terbinafine (Lamisil) Product and Services
Table 30. Sivem Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Apotex Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Apotex Corporation Major Business
Table 33. Apotex Corporation Terbinafine (Lamisil) Product and Services
Table 34. Apotex Corporation Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Auro Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 36. Auro Pharma Inc Major Business
Table 37. Auro Pharma Inc Terbinafine (Lamisil) Product and Services
Table 38. Auro Pharma Inc Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. PLIVA Basic Information, Manufacturing Base and Competitors
Table 40. PLIVA Major Business
Table 41. PLIVA Terbinafine (Lamisil) Product and Services
Table 42. PLIVA Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Jamp Pharma Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Jamp Pharma Corporation Major Business
Table 45. Jamp Pharma Corporation Terbinafine (Lamisil) Product and Services
Table 46. Jamp Pharma Corporation Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Nu Pharm Basic Information, Manufacturing Base and Competitors
Table 48. Nu Pharm Major Business
Table 49. Nu Pharm Terbinafine (Lamisil) Product and Services
Table 50. Nu Pharm Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Codal Synto Basic Information, Manufacturing Base and Competitors
Table 52. Codal Synto Major Business
Table 53. Codal Synto Terbinafine (Lamisil) Product and Services
Table 54. Codal Synto Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Qd Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Qd Pharmaceuticals Major Business
Table 57. Qd Pharmaceuticals Terbinafine (Lamisil) Product and Services
Table 58. Qd Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Pharmel Inc Basic Information, Manufacturing Base and Competitors
Table 60. Pharmel Inc Major Business
Table 61. Pharmel Inc Terbinafine (Lamisil) Product and Services
Table 62. Pharmel Inc Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Smaart Pharmaceutticals Basic Information, Manufacturing Base and Competitors
Table 64. Smaart Pharmaceutticals Major Business
Table 65. Smaart Pharmaceutticals Terbinafine (Lamisil) Product and Services
Table 66. Smaart Pharmaceutticals Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Qilu Pharmaceutical Major Business
Table 69. Qilu Pharmaceutical Terbinafine (Lamisil) Product and Services
Table 70. Qilu Pharmaceutical Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Qingdao Jinfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Qingdao Jinfeng Pharmaceutical Major Business
Table 73. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product and Services
Table 74. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Terbinafine (Lamisil) Sales by Manufacturer (2019-2021e) & (KG)
Table 76. Global Terbinafine (Lamisil) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Terbinafine (Lamisil), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Terbinafine (Lamisil) Production Capacity by Company, (KG): 2020 VS 2021
Table 79. Head Office and Terbinafine (Lamisil) Production Site of Key Manufacturer
Table 80. Terbinafine (Lamisil) New Entrant and Capacity Expansion Plans
Table 81. Terbinafine (Lamisil) Mergers & Acquisitions in the Past Five Years
Table 82. Global Terbinafine (Lamisil) Sales by Region (2016-2021e) & (KG)
Table 83. Global Terbinafine (Lamisil) Sales by Region (2021-2026) & (KG)
Table 84. Global Terbinafine (Lamisil) Revenue by Region (2016-2021e) & (USD Million)
Table 85. Global Terbinafine (Lamisil) Revenue by Region (2021-2026) & (USD Million)
Table 86. Global Terbinafine (Lamisil) Sales by Type (2016-2021e) & (KG)
Table 87. Global Terbinafine (Lamisil) Sales by Type (2021-2026) & (KG)
Table 88. Global Terbinafine (Lamisil) Revenue by Type (2016-2021e) & (USD Million)
Table 89. Global Terbinafine (Lamisil) Revenue by Type (2021-2026) & (USD Million)
Table 90. Global Terbinafine (Lamisil) Price by Type (2016-2021e) & (US$/G)
Table 91. Global Terbinafine (Lamisil) Price by Type (2021-2026) & (US$/G)
Table 92. Global Terbinafine (Lamisil) Sales by Application (2016-2021e) & (KG)
Table 93. Global Terbinafine (Lamisil) Sales by Application (2021-2026) & (KG)
Table 94. Global Terbinafine (Lamisil) Revenue by Application (2016-2021e) & (USD Million)
Table 95. Global Terbinafine (Lamisil) Revenue by Application (2021-2026) & (USD Million)
Table 96. Global Terbinafine (Lamisil) Price by Application (2016-2021e) & (US$/G)
Table 97. Global Terbinafine (Lamisil) Price by Application (2021-2026) & (US$/G)
Table 98. North America Terbinafine (Lamisil) Sales by Country (2016-2021e) & (KG)
Table 99. North America Terbinafine (Lamisil) Sales by Country (2021-2026) & (KG)
Table 100. North America Terbinafine (Lamisil) Revenue by Country (2016-2021e) & (USD Million)
Table 101. North America Terbinafine (Lamisil) Revenue by Country (2021-2026) & (USD Million)
Table 102. North America Terbinafine (Lamisil) Sales by Type (2016-2021e) & (KG)
Table 103. North America Terbinafine (Lamisil) Sales by Type (2021-2026) & (KG)
Table 104. North America Terbinafine (Lamisil) Sales by Application (2016-2021e) & (KG)
Table 105. North America Terbinafine (Lamisil) Sales by Application (2021-2026) & (KG)
Table 106. Europe Terbinafine (Lamisil) Sales by Country (2016-2021e) & (KG)
Table 107. Europe Terbinafine (Lamisil) Sales by Country (2021-2026) & (KG)
Table 108. Europe Terbinafine (Lamisil) Revenue by Country (2016-2021e) & (USD Million)
Table 109. Europe Terbinafine (Lamisil) Revenue by Country (2021-2026) & (USD Million)
Table 110. Europe Terbinafine (Lamisil) Sales by Type (2016-2021e) & (KG)
Table 111. Europe Terbinafine (Lamisil) Sales by Type (2021-2026) & (KG)
Table 112. Europe Terbinafine (Lamisil) Sales by Application (2016-2021e) & (KG)
Table 113. Europe Terbinafine (Lamisil) Sales by Application (2021-2026) & (KG)
Table 114. Asia-Pacific Terbinafine (Lamisil) Sales by Region (2016-2021e) & (KG)
Table 115. Asia-Pacific Terbinafine (Lamisil) Sales by Region (2021-2026) & (KG)
Table 116. Asia-Pacific Terbinafine (Lamisil) Revenue by Region (2016-2021e) & (USD Million)
Table 117. Asia-Pacific Terbinafine (Lamisil) Revenue by Region (2021-2026) & (USD Million)
Table 118. Asia-Pacific Terbinafine (Lamisil) Sales by Type (2016-2021e) & (KG)
Table 119. Asia-Pacific Terbinafine (Lamisil) Sales by Type (2021-2026) & (KG)
Table 120. Asia-Pacific Terbinafine (Lamisil) Sales by Application (2016-2021e) & (KG)
Table 121. Asia-Pacific Terbinafine (Lamisil) Sales by Application (2021-2026) & (KG)
Table 122. South America Terbinafine (Lamisil) Sales by Country (2016-2021e) & (KG)
Table 123. South America Terbinafine (Lamisil) Sales by Country (2021-2026) & (KG)
Table 124. South America Terbinafine (Lamisil) Revenue by Country (2016-2021e) & (USD Million)
Table 125. South America Terbinafine (Lamisil) Revenue by Country (2021-2026) & (USD Million)
Table 126. South America Terbinafine (Lamisil) Sales by Type (2016-2021e) & (KG)
Table 127. South America Terbinafine (Lamisil) Sales by Type (2021-2026) & (KG)
Table 128. South America Terbinafine (Lamisil) Sales by Application (2016-2021e) & (KG)
Table 129. South America Terbinafine (Lamisil) Sales by Application (2021-2026) & (KG)
Table 130. Middle East & Africa Terbinafine (Lamisil) Sales by Country (2016-2021e) & (KG)
Table 131. Middle East & Africa Terbinafine (Lamisil) Sales by Country (2021-2026) & (KG)
Table 132. Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2016-2021e) & (USD Million)
Table 133. Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Terbinafine (Lamisil) Sales by Type (2016-2021e) & (KG)
Table 135. Middle East & Africa Terbinafine (Lamisil) Sales by Type (2021-2026) & (KG)
Table 136. Middle East & Africa Terbinafine (Lamisil) Sales by Application (2016-2021e) & (KG)
Table 137. Middle East & Africa Terbinafine (Lamisil) Sales by Application (2021-2026) & (KG)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Terbinafine (Lamisil) Typical Distributors
Table 141. Terbinafine (Lamisil) Typical Customers
List of Figures
Figure 1. Terbinafine (Lamisil) Picture
Figure 2. Global Terbinafine (Lamisil) Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. External Use
Figure 5. Global Terbinafine (Lamisil) Sales Market Share by Application in 2020
Figure 6. Fungal Infection Of The Skin And Mucous Membrane
Figure 7. Onychomycosis
Figure 8. Bronchial Asthma
Figure 9. Gynecological Anti-Infection Preparation
Figure 10. Other
Figure 11. Global Terbinafine (Lamisil) Market Size, (USD Million) & (KG): 2020 VS 2021 VS 2026
Figure 12. Global Terbinafine (Lamisil) Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Terbinafine (Lamisil) Sales (2016-2026) & (KG)
Figure 14. Global Terbinafine (Lamisil) Price by Type (2016-2026) & (US$/G)
Figure 15. Global Terbinafine (Lamisil) Production Capacity (2016-2026) & (KG)
Figure 16. Global Terbinafine (Lamisil) Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Terbinafine (Lamisil) Market Drivers
Figure 18. Terbinafine (Lamisil) Market Restraints
Figure 19. Terbinafine (Lamisil) Market Trends
Figure 20. Global Terbinafine (Lamisil) Sales Market Share by Manufacturer in 2020
Figure 21. Global Terbinafine (Lamisil) Revenue Market Share by Manufacturer in 2020
Figure 22. Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Terbinafine (Lamisil) Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Terbinafine (Lamisil) Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Terbinafine (Lamisil) Sales Market Share by Region (2016-2026)
Figure 26. Global Terbinafine (Lamisil) Revenue Market Share by Region (2016-2026)
Figure 27. North America Terbinafine (Lamisil) Revenue (2016-2026) & (USD Million)
Figure 28. Europe Terbinafine (Lamisil) Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Terbinafine (Lamisil) Revenue (2016-2026) & (USD Million)
Figure 30. South America Terbinafine (Lamisil) Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Terbinafine (Lamisil) Revenue (2016-2026) & (USD Million)
Figure 32. Global Terbinafine (Lamisil) Sales Market Share by Type (2016-2026)
Figure 33. Global Terbinafine (Lamisil) Revenue Market Share by Type (2016-2026)
Figure 34. Global Terbinafine (Lamisil) Price by Type (2016-2026) & (US$/G)
Figure 35. Global Terbinafine (Lamisil) Sales Market Share by Application (2016-2026)
Figure 36. Global Terbinafine (Lamisil) Revenue Market Share by Application (2016-2026)
Figure 37. Global Terbinafine (Lamisil) Price by Application (2016-2026) & (US$/G)
Figure 38. North America Terbinafine (Lamisil) Sales Market Share by Type (2016-2026)
Figure 39. North America Terbinafine (Lamisil) Sales Market Share by Application (2016-2026)
Figure 40. North America Terbinafine (Lamisil) Sales Market Share by Country (2016-2026)
Figure 41. North America Terbinafine (Lamisil) Revenue Market Share by Country (2016-2026)
Figure 42. United States Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Terbinafine (Lamisil) Sales Market Share by Type (2016-2026)
Figure 46. Europe Terbinafine (Lamisil) Sales Market Share by Application (2016-2026)
Figure 47. Europe Terbinafine (Lamisil) Sales Market Share by Country (2016-2026)
Figure 48. Europe Terbinafine (Lamisil) Revenue Market Share by Country (2016-2026)
Figure 49. Germany Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Terbinafine (Lamisil) Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Terbinafine (Lamisil) Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Terbinafine (Lamisil) Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Terbinafine (Lamisil) Revenue Market Share by Region (2016-2026)
Figure 58. China Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Terbinafine (Lamisil) Sales Market Share by Type (2016-2026)
Figure 65. South America Terbinafine (Lamisil) Sales Market Share by Application (2016-2026)
Figure 66. South America Terbinafine (Lamisil) Sales Market Share by Country (2016-2026)
Figure 67. South America Terbinafine (Lamisil) Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Terbinafine (Lamisil) Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Terbinafine (Lamisil) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
塩酸テルビナフィン薬の世界市場2018-2025 Terbinafine, sold under the brand name Lamisil among others, an antifungal medication used to treat pityriasis versicolor, fungal nail infections, and ringworm including jock itch and athlete's foot. It is either taken by mouth or applied to the skin as a cream or ointment. The cream and ointment ar…- 皮膚・粘膜消毒剤の世界市場2018-2025 The Skin and Mucous Membrane Disinfectants market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for…
- 抗原皮膚試験の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Antigen Skin Test is mainly performed so that the immune systems can be tested against the antigens. Scope of the Report: This report focuses on the Antigen Skin Test in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorize…
- 世界のブドウ球菌感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Staphylococcal Infection Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の細菌性眼感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Bacterial Eye Infection Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …